psoriasis
Conditions
Interventions
Intervention group:Moxibustion
Control group:external use of Calcipotriol Ointment
Sponsors
Beijing Institute of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Comply with Chinese and Western diagnostic criteria for psoriasis vulgaris; (2) Comply with the syndrome differentiation standard of psoriasis blood stasis syndrome; (3) No new skin lesions appeared in the past two weeks, and the lesions were mainly plaque-type; (4) The condition is mild and moderate, the overall lesion area = 10% of the body surface area, and the single lesion area = 1% of the body surface area; (5) The stage of illness is the stationary phase and the extinction phase; (6) Aged between 18 and 65 years; (7) Sign the informed consent form and volunteer to be tested.
Exclusion criteria
Exclusion criteria: (1) In the past month, glucocorticoids and / or immunosuppressive drugs, and retinoic acid drugs or two-week glucocorticoid preparations, calcineurin inhibitors, retinoids and vitamin D3 derivative preparations; (2) Pregnant or lactating women; (3) Patients with severe primary diseases and mental illnesses such as cardiovascular, cerebrovascular, and hematopoietic systems; (4) Those who are allergic to research drugs; (5) Patients who participated in other drug clinical trials without the consent of the research doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Target lesion clinical effectiveness;Target lesion recurrence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Target lesion onset time;Target lesion change;Overall clinical effectiveness;Overall clinical cure rate;Overall clinical improvement rate;Skin disease quality of life index;TCM syndrome efficacy score;Target recurrence interval;Target skin lesion rebound rate; | — |
Countries
China
Contacts
Public ContactChen Zhaoxia
Beijing Institute of Traditional Chinese Medicine
Outcome results
None listed